Corporate Information

Sequent Scientific Ltd Industry : (Pharmaceuticals)

BSE Code : 512529

NSE Symbol : SEQUENT

P/E(TTM) : 361.15

ISIN Demat : INE807F01027

Div & Yield% : -

EPS(TTM) : 0.48

Book Value(₹) : 43.56

Market Cap(₹Cr) : 4,326.50

Face Value(₹) : 2.00

Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 168.52 222.69 219.63 265.46 227.33
Excise Duty - - - - -
Net Sales 168.52 222.69 219.63 265.46 227.33
Other Income 45.98 28.24 27.64 19.97 14.56
Stock Adjustments -5.35 -19.42 19.73 15.56 3.89
Total Income 209.15 231.51 267.00 300.99 245.78
EXPENDITURE :          
Raw Materials 102.54 116.50 128.39 124.43 116.93
Power and Fuel Cost 12.89 13.93 11.96 12.77 12.74
Other Manufacturing Expenses 26.21 41.54 52.53 57.73 50.56
Selling and Administration Expenses 17.86 19.49 19.40 20.27 9.98
Miscellaneous Expenses 6.54 1.52 0.45 10.68 1.68
Employee Benefit Expenses 30.05 36.66 27.38 22.42 17.10
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit 13.06 1.88 26.89 52.70 36.80
Interest 4.36 2.51 1.61 2.68 5.04
Gross Profit 8.70 -0.63 25.28 50.02 31.76
Depreciation 8.94 9.12 9.59 9.13 8.95
Profit Before Tax -0.24 -9.75 15.69 40.89 22.81
Current Tax 0.46 -0.57 0.37 6.09 3.18
Fringe Benefit tax - - - - -
Deferred Tax -1.32 -3.09 0.52 2.69 -1.71
Reported Net Profit 0.62 -6.08 14.80 32.11 21.34
Extraordinary Items -1.69 - - -0.75 -
Adjusted Net Profit 2.31 -6.08 14.80 32.86 21.34
Adjustment below Net Profit 2.65 0.09 0.07 43.38 -1.30
Profit/Loss Balance carried down 38.76 30.56 28.03 -47.47 -62.65
Statutory Appropriations - - - - -
Appropriations - -14.19 12.34 - 4.86
P & L Balance carried down 42.03 38.76 30.56 28.03 -47.47
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - 25.00 -
Dividend Per Share(Rs) - - - 0.50 -
Earnings Per Share-Unit Curr 0.02 -0.24 0.60 1.29 0.86
Earnings Per Share(Adj)-Unit Curr 0.02 -0.24 0.60 1.29 0.86
Book Value 43.59 42.43 41.55 41.45 35.68
Book Value(Adj)-Unit Curr 43.59 42.43 41.55 41.45 35.68